1,430
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Superior anti-neoplastic activities of triacontanol-PEG conjugate: synthesis, characterization and biological evaluations

, , , , , , , & show all
Pages 1546-1559 | Received 13 Apr 2018, Accepted 14 May 2018, Published online: 19 Jul 2018

References

  • Abet V, Filace F, Recio J, et al. (2017). Prodrug approach: an overview of recent cases. Eur J Med Chem 127:810–27.
  • Bailon P, Won CY. (2009). PEG-modified biopharmaceuticals. Expert Opin Drug Deliv 6:1–16.
  • Chu B, Qu Y, Huang Y, et al. (2016). PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Int J Pharm 500:345–59.
  • Croix BS, Rago C, Velculescu V, et al. (2000). Genes expressed in human tumor endothelium. Science 289:1197–202.
  • DiDonato JA, Mercurio F, Karin M. (2012). NF-κB and the link between inflammation and cancer. Immunol Rev 246:379–400.
  • Dullens SPJ, Mensink RP, Bragt MCE, et al. (2008). Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice. J Lipid Res 49:790–6.
  • Fan X, Zhang R, Cheng H. 2006. Use of Triacontanol in Preparation of Medicaments for Treatment of Cancers. CN101190210B;US 7863337 B2;US 20100041924 A1.
  • Gong J, Qin X, Yuan F, et al. (2017). Efficacy and safety of sugarcane policosanol on dyslipidemia: a meta-analysis of randomized controlled trials. Mol Nutr Food Res 62. doi: 10.1002/mnfr.201700280
  • Haim D, Berrios M, Valenzuela A, Videla LA. (2009). Trace quantification of 1-octacosanol and 1-triacontanol and their main metabolites in plasma by liquid–liquid extraction coupled with gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:4154–8.
  • Hamley IW. (2014). PEG-peptide conjugates. Biomacromolecules 15:1543–59.
  • Jalava P, Kuopio T, Juntti-Patinen L, et al. (2006). Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index. Histopathology 48:674–82.
  • Kadajji VG, Betageri GV. (2011). Water soluble polymers for pharmaceutical applications. Polymers 3:1972.
  • Kim JY, Kim SM, Kim SJ, et al. (2017). Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects. Int J Mol Med 39:889–99.
  • Kruth HS, Jones NL, Huang W, et al. (2005). Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem 280:2352–60.
  • Li YF, Xu XB, Chen XH, et al. (2012). The nuclear factor-kappaB pathway is involved in matrix metalloproteinase-9 expression in RU486-induced endometrium breakdown in mice. Hum Reprod (Oxford, England) 27:2096–106.
  • Li W, Zhan P, De Clercq E, et al. (2013). Current drug research on PEGylation with small molecular agents. Prog Polym Sci 38:421–44.
  • Mahato R, Tai W, Cheng K. (2011). Prodrugs for improving tumor targetability and efficiency. Adv Drug Deliv Rev 63:659–70.
  • Naeem M, Khan MMA.Moinuddin (2012). Triacontanol: a potent plant growth regulator in agriculture. J Plant Interact 7:129–42.
  • Paik MJ, Yu J, Hu MB, et al. (2008). Gas chromatographic-mass spectrometric analyses of cholesterol and its precursors in rat plasma as tert-butyldimethylsilyl derivatives. Clin Chim Acta 396:62–5.
  • Pan J, Fauzee NJ, Wang YL, et al. (2012). Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation. Cancer Gene Ther 19:715–22.
  • Pasut G, Veronese FM. (2009). PEG conjugates in clinical development or use as anticancer agents: an overview. Adv Drug Deliv Rev 61:1177–88.
  • Raina K, Agarwal C, Agarwal R. (2013). Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling. Mol Carcinog 52:195–206.
  • Rejman J, Bragonzi A, Conese M. (2005). Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther 12:468–74.
  • Sahay G, Alakhova DY, Kabanov AV. (2010). Endocytosis of nanomedicines. J Control Release 145:182–95.
  • Schmid S, Carter LL. (1990). ATP is required for receptor-mediated endocytosis in intact cells. J Cell Bio 111:2307–18.
  • Senevirathne SA, Washington KE, Biewer MC, Stefan MC. (2016). PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents. J Mater Chem B 4:360–70.
  • Shen J, Zhang D, Zhao Z, et al. (2013). Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates. Int J Pharm 456:80–6.
  • Shibata A, Nagaya T, Imai T, et al. (2002). Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat 73:237–43.
  • Singh DK, Li L, Porter TD. (2006). Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J.Pharmacol Exp Ther 318:1020–6.
  • Stefan N, Zimmermann M, Simon M, et al. (2014). Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting. Bioconjugate Chem 25:2144–56.
  • Thippeswamy G, Sheela ML, Salimath BP. (2008). Octacosanol isolated from Tinospora cordifolia downregulates VEGF gene expression by inhibiting nuclear translocation of NF-<kappa > B and its DNA binding activity. Eur J Pharmacol 588:141–50.
  • Veronese FM, Pasut G. (2005). PEGylation, successful approach to drug delivery. Drug Discov Today 10:1451–8.
  • Wang Z, Banerjee S, Li Y, et al. (2006). Down-regulation of Notch-1 inhibits invasion by inactivation of nuclear factor-κB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 66:2778–84.
  • Wang C, Fan A, Deng S, et al. (2015). Investigation on pharmacokinetics, tissue distribution and excretion of 1-triacontanol in rats by gas chromatography-tandem mass spectrometry (GC-MS/MS). Xenobiotica 45:71–8.
  • Wichitnithad W, Nimmannit U, Callery PS, Rojsitthisak P. (2011). Effects of different carboxylic ester spacers on chemical stability, release characteristics, and anticancer activity of mono-PEGylated curcumin conjugates. J Pharm Sci 100:5206–18.
  • Yameen B, Choi WI, Vilos C, et al. (2014). Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release 190:485–99.
  • Yang Y, Lu X, Liu Q, et al. (2017). Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Eur J Pharm Sci 105:219–29.
  • Zhang R, Fan X, Duan Y, Wang K. (2016). Application of COX 2 and VEGF inhibitors and thirty alkanol. CN106727451A.
  • Zhang F, Guo H, Zhang J, et al. (2018). Identification of the caveolae/raft-mediated endocytosis as the primary entry pathway for aquareovirus. Virology 513:195–207.